3B Blackbio Dx Ltd. (3BBLACKBIO): 3B Blackbio Dx Ltd 52 Week High Streak Holds For Second Straight Session

3B Blackbio Dx Ltd 52 Week High Streak has now stretched to its second straight session, with the stock trading within 2% of its one-year peak and moving 6.15% across the streak. The latest peak stood at Rs 1,731.85 and the stock was last traded at Rs 1,725. The latest Univest figures confirm the repeated-high pattern, but they do not establish a company-specific catalyst for the continued move.

In the latest session, 3B Blackbio Dx Ltd Share Price stood above the previous close of Rs 1,693.15, after opening at Rs 1,690.95 and touching a low of Rs 1,676.05. The market capitalisation was Rs 1,394.77 crore. For readers, a repeated near-high pattern carries a different meaning from a one-day move: it shows that the stock has stayed near its yearly high zone across multiple sessions, without turning that into a fresh all-time high claim.

3B Blackbio Dx Ltd 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 1,725
Previous Close	Rs 1,693.15
Today's Move	+Rs 31.85 (+1.88%)
Open	Rs 1,690.95
High	Rs 1,731.85
Low	Rs 1,676.05
Market Capitalisation	Rs 1,394.77 crore

3B Blackbio Dx Ltd. (3BBLACKBIO) traded at Rs 1,725 versus the previous close of Rs 1,693.15, a rise of 1.88%. The stock opened at Rs 1,690.95, reached a high of Rs 1,731.85 and touched a low of Rs 1,676.05.

3B Blackbio Dx Ltd Share Price Today reflected a firm intraday position as the stock moved between Rs 1,676.05 and Rs 1,731.85 and was last traded at Rs 1,725, up Rs 31.85 or 1.88% from the previous close. The open at Rs 1,690.95 left the price near the upper end of the day’s range, and the latest reading kept the stock close to its 52-week high without implying a breakout beyond it. The market capitalisation at Rs 1,394.77 crore places 3B Blackbio Dx Ltd among the more closely watched names in its segment. For 3B Blackbio Dx Ltd Share Price watchers, the key point is not just the day move, but the fact that the stock has remained near its yearly high for another session.

What the Repeated 52-Week Highs Show

3B Blackbio Dx Ltd 52 Week High Streak indicates that the stock has remained near its yearly peak for two consecutive sessions, and the cumulative move across that run is 6.15%. The latest high of Rs 1,731.85 frames the streak, while the current trading level remains close enough to keep the stock in the 52-week high zone. This 3B Blackbio Dx Ltd Stock News event is best read as a pattern of repeated proximity to the one-year high, not as a fresh claim that the stock has set a new record.

What matters in a 3B Blackbio Dx Ltd 52 Week High Streak article is the cumulative behaviour across sessions, not only the latest rupee move. The present pattern also shows that the recent high is being revisited rather than ignored. The latest Univest data confirms the price pattern, but it does not establish whether any specific corporate development or market event is responsible. For readers scanning Stocks At One Year High Today or Stocks Hitting 52 Week Highs, this is the kind of repeated near-high structure that often keeps a stock in the spotlight.

3B Blackbio Dx Ltd. (3BBLACKBIO) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,394.77 crore
P/E Ratio	26.17x
P/B Ratio	4.36x
ROE	20.22%
ROCE	25.9%
EPS	Rs 64.7
Book Value Per Share	Rs 388.43
Dividend Yield	0.3%

3B Blackbio Dx Ltd. (3BBLACKBIO) fundamental metrics show P/E 26.17x, P/B 4.36x, ROE 20.22%, ROCE 25.9%. These figures provide context only and are not a buy or sell signal.

3B Blackbio Dx Ltd. has a market capitalisation of Rs 1394.77 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 26.17x, P/B at 4.36x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.22% and ROCE of 25.9%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 64.7, book value per share of Rs 388.43, dividend yield of 0.3%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 34.12x, median ROE of 12.73%, median ROCE of 14.05%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Medical Equipment/Supplies/Accessories
Benchmark Scope	same industry
Company P/E Ratio	26.17x
Benchmark Median P/E	34.12x
Benchmark Average P/E	90.25x
Benchmark P/E Range	0x to 1,027.7x
Company P/B Ratio	4.36x
Benchmark Median P/B	3.74x
Company ROE	20.22%
Benchmark Median ROE	12.73%
Company ROCE	25.9%
Benchmark Median ROCE	14.05%
Company Market Capitalisation	Rs 1,394.77 crore
Benchmark Median Market Cap	Rs 178.8 crore

3B Blackbio Dx Ltd. (3BBLACKBIO) is classified under sector: Healthcare and industry: Medical Equipment/Supplies/Accessories.

3B Blackbio Dx Ltd. (3BBLACKBIO) has a P/E ratio of 26.17x, which is below the benchmark median of 34.12x, a difference of -23.3%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

3B Blackbio Dx Ltd. (3BBLACKBIO) has a ROE of 20.22%, which is above the benchmark median of 12.73%, a difference of +58.84%. 3B Blackbio Dx Ltd. (3BBLACKBIO) has a ROCE of 25.9%, which is above the benchmark median of 14.05%, a difference of +84.34%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Q-LINE BIOTECH LIMITED	QLINE	1,569.4	28.51	6.27	25.55	22.23
LAXMI DENTAL LIMITED	LAXMIDENTL	1,057.39	34.12	4.29	11.95	13.29
Hemant Surgical Industries Ltd.	HSIL	868.62	48.7	6.16	12.73	13.58
Osel Devices Ltd.	OSELDEVICE	682.24	23.33	6.22	30.09	31.15
Prevest Denpro Ltd.	PREVEST	462.06	20.99	3.5	17.79	24.21

3B Blackbio Dx Ltd. (3BBLACKBIO) has a P/E ratio of 26.17x compared with the displayed peer median of 28.51x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.22% compares with a peer median of 17.79% across the companies shown in the table. ROCE stood at 25.9% versus the displayed peer median of 22.23%, providing a capital-efficiency comparison. 3B Blackbio Dx Ltd. (3BBLACKBIO) has a market capitalisation of Rs 1,394.77 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching 3B Blackbio Dx Ltd

• 3B Blackbio Dx Ltd 52 Week High Streak has extended to a second straight session.
• The cumulative move across the streak stands at 6.15%.
• The latest high of Rs 1,731.85 keeps the stock close to its yearly peak.
• 3B Blackbio Dx Ltd Fundamental Analysis shows a P/E below the industry median.
• The company’s ROE and ROCE remain above the selected industry medians.

About 3B Blackbio Dx Ltd

3B Blackbio Dx Ltd is part of the Healthcare sector and the Medical Equipment/Supplies/Accessories industry. The company’s latest market capitalisation is Rs 1,394.77 crore, and its share price action has recently kept it in the bracket of Stocks In News Today and Stocks At One Year High Today. For readers tracking 3B Blackbio Dx Ltd Stock Performance, the main interest is the combination of near-high trading, valuation context and return ratios.

The company’s stock is listed on NSE and BSE, and its latest numbers place it among the more closely watched names in its industry. For anyone following 3B Blackbio Dx Ltd Share Price Today, the important read-through is that the streak is real, the valuation can be compared with peers, and the price remains near the 52-week high zone without turning that into a new all-time high claim.

Frequently Asked Questions

What does the 3B Blackbio Dx Ltd 52 Week High Streak mean?

Ans. It means 3B Blackbio Dx Ltd has traded within 2% of its 52-week high for a second straight session. The pattern shows repeated near-high trading, which can keep the stock on watch for readers tracking 52 Week High Stocks and the 3B Blackbio Dx Ltd.

How long has 3B Blackbio Dx Ltd stayed near its one-year high?

Ans. The stock has stayed near its one-year high for two consecutive sessions. The latest streak data shows a cumulative move of 6.15%, making this a notable 3B Blackbio Dx Ltd 52 Week High Streak rather than a one-off price move.

Has 3B Blackbio Dx Ltd made a new all-time high?

Ans. No all-time high claim is being made here. The event confirms that the stock traded near its 52-week high, not that it set a lifetime record. The focus remains on the repeated 52-week high pattern in 3B Blackbio Dx Ltd Stock News.

What was the latest price action in 3B Blackbio Dx Ltd Share Price Today?

Ans. The stock was last traded at Rs 1,725 after opening at Rs 1,690.95 and moving between Rs 1,676.05 and Rs 1,731.85. It was up Rs 31.85 or 1.88% from the previous close.

What does the fundamental picture show for 3B Blackbio Dx Ltd?

Ans. 3B Blackbio Dx Ltd Fundamental Analysis shows a P/E of 26.17, P/B of 4.36, ROE of 20.22% and ROCE of 25.9%. These figures place the company below the industry median on earnings multiple and above the median on return ratios.

How does 3B Blackbio Dx Ltd compare with peers?

Ans. Compared with selected peers in the same industry, 3B Blackbio Dx Ltd trades at a lower P/E than Q-LINE BIOTECH LIMITED, LAXMI DENTAL LIMITED and Hemant Surgical Industries Ltd. Its return ratios are also stronger than several names in the comparison set, supporting a steady.

Should investors track 3B Blackbio Dx Ltd breakout behaviour?

Ans. Investors tracking 3B Blackbio Dx Ltd Stock Performance may monitor whether the stock continues to trade near the yearly peak and how it behaves relative to peer valuations. The latest numbers confirm the streak, but they do not establish a specific catalyst or a recommendation.

Track 3B Blackbio Dx Ltd. (3BBLACKBIO) Share Price on Univest

Use 3B Blackbio Dx Ltd. (3BBLACKBIO) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.